Informal harmonisation of EU authorised representative role is recipe for confusion
This article was originally published in SRA
Executive Summary
The new European Commission guideline on the role and responsibilities of EU-based authorised representatives in the medical device sector is laudable in its aims. However, it is likely to cause confusion – or worse – when stakeholders seek to work with it, Erik Vollebregt tells Ashley Yeo.